問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2022-01-03 - 2022-10-28
Condition/Disease
Test Drug
Participate Sites4Sites
Recruiting4Sites
2020-12-26 - 2022-06-30
COVID-19
MVC-COV1901 vaccine
Participate Sites11Sites
Not yet recruiting7Sites
Recruiting1Sites
Terminated3Sites
2021-03-02 - 2024-06-16
Participate Sites5Sites
Terminated5Sites
2017-11-01 - 2021-12-08
Acute primary cerebral hemorrhage
Three-dose combination(telmisartan, amlodipine, indapamide)
Recruiting3Sites
Study ended1Sites
Division of Neurology
2013-12-01 - 2016-05-31
Participate Sites2Sites
Terminated2Sites
2011-04-13 - 2013-12-31
Participate Sites1Sites
Terminated1Sites
2012-03-15 - 2014-04-30
2008-04-01 - 2012-10-31
2020-06-15 - 2022-03-20
vitiligo
Tofacitinib
2021-05-03 - 2023-02-28
Participate Sites3Sites
全部
